CLPT vs IART
CLPT: ClearPoint Neuro provides advanced image-guided navigation and delivery platforms to enable precise, minimally invasive neurosurgical procedures. IART: A global medical technology firm specializing in innovative surgical instrumentation, neurosurgical devices, and regenerative tissue repair solutions.
Side-by-side fundamentals
| Metric | CLPT | IART | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $14.60 | $19.53 | |
| Market cap as of 2026-08-06 | $438M | $1.5B | |
| PEG as of 2026-08-06 | -0.23 | 1.40 | CLPT lower |
| Net margin as of 2026-08-06 | -71.6% | -0.4% | IART higher |
| Gross margin as of 2026-08-06 | +62.3% | +57.2% | CLPT higher |
| Operating margin as of 2026-08-06 | -65.2% | +4.0% | IART higher |
| ROE as of 2026-08-06 | -141.0% | -0.7% | IART higher |
| ROA as of 2026-08-06 | -37.0% | -0.2% | IART higher |
| Debt / equity as of 2026-08-06 | 2.63 | 1.79 | IART lower |
| Revenue growth (YoY) as of 2026-08-06 | +26.0% | +1.6% | CLPT higher |
| Revenue CAGR (3y) SEC XBRL | +21.6% | +1.6% | CLPT higher |
| Beta as of 2026-08-06 | 1.20 | 1.23 | |
| 1-year return as of 2026-07-27 close | +30.0% | +49.0% | IART higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.